News and Trends 16 Feb 2023
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy,…
Melanoma
- Latest Posts
News and Trends 1 Nov 2022
Proscia presents results on AI melanoma diagnostic predictions
Proscia has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of…
News and Trends 5 Oct 2022
OncoSec slashing staff numbers to prioritize pipeline
OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP). TAVO is a plasmid encoding…
Sponsored by Biognosys
27 Sep 2022Using the power of proteomics to predict immunotherapy responses in melanoma and beyond
Next-generation proteomics has a vital role to play in the search for new biomarkers of immunotherapy response. Recent studies in…
ADVERTISEMENT
News and Trends 22 Sep 2022
Swiss scientists reduce resistance of dormant melanoma cells
Small-molecule targeted therapies revolutionized the treatment of metastatic melanoma, provided that the tumors carry the mutations to respond to these…
News and Trends 6 Nov 2019
UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer vaccines and cell therapies that…
News and Trends 3 Sep 2019
UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell immunotherapies in humans for the…
Startup Scout 5 Jul 2019
This Biotech Helps the Immune System to Infiltrate and Destroy Tumors
The Nice-based biotech company Yukin Therapeutics is developing drugs that can work together with checkpoint inhibitors to help the immune…
Interview 24 Jul 2018
Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”
Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us…
News and Trends 12 Dec 2017
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100 available to patients with uveal melanoma…
ADVERTISEMENT
News and Trends 13 Nov 2017
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for its TCR immunotherapy IMCgp100 in…
News and Trends 27 Jul 2017
Swiss Researchers Unveil Cancer Immunotherapy Resistance Mechanism
Scientists from the University of Zurich have identified an epigenetic control switch responsible for turning melanoma unresponsive to immune checkpoint…
News and Trends 30 Jun 2017
Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy based on off-the-shelf mRNA technology. eTheRNA is…
Startup Scout 2 Jun 2017
This French Biotech Wants to Reinvent DC-based Immunotherapies
This week we had the chance to visit both Grenoble and Liège, where the French-Belgian biotech hybrid PDC*line Pharma has…
News and Trends 22 May 2017
Norwegian Biotech Goes for Combination Therapies in Melanoma
BerGenBio has started a new Phase I/II trial evaluating the addition of its Axl inhibitor to standard of care treatments…
News and Trends 16 Dec 2016
Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis
Amcure and TILT Biotherapeutics announced yesterday new financing rounds supporting the development of unique strategies to cure cancer metastasis. Amcure,…
ADVERTISEMENT
News and Trends 1 Dec 2016
7 European Institutions in the Largest Cancer Bioinformatics Collaboration
Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration aimed at developing personalized cancer…
News and Trends 18 Nov 2016
Can Oncolytic Viruses be the key to Treat Resistant Tumors?
This week, we leave Belgium and keep traveling north to Oslo, where snow is starting to pack for the joy…
News and Trends 10 Nov 2016
European Biotech is working hard to Beat back Melanoma
Immunocore and Pierre Fabre have been representing Europe in this years' Society for Melanoma Research Congress. This type of cancer may…
News and Trends 2 Jun 2016
First All-Cancer mRNA Vaccine that Works Published in Nature
Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all 13 patients treated with its…
